JPRN-UMIN000015019招募中未知
Initial therapy for myasthenia gravis of combined therapy for tacrolimus and IVIG - Combined therapy for tacrolimus and IVIG
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •indication for thymectomy
研究者
相似试验
已完成
不适用
Treatment of MuSK antibody-positive myasthenia gravis with rituximab: an exploratory clinical studyMuSK antibody-positive myasthenia gravisJPRN-UMIN000012089Department of Neurology University of Tokyo, Graduate School of Medicine5
招募中
不适用
Myasthenia gravis - In-depth characterization of antibody-specific pathomechanisms and identification of novel autoantibodies.G70.0Myasthenia gravisDRKS00025711Klinik für Neurologie, Charité- Universitätsmedizin Berlin150
已完成
2 期
Effect of Rituximab in treatment of myasthenia gravisMyasthenia gravis.G70.0Myasthenia gravisIRCT20190324043105N2Esfahan University of Medical Sciences10
已完成
Unknown
Treatment of Myasthenia Gravis (MG) Focusing on Corticosteroid Dose: An Insurance Claims Database Study in JapaMyasthenia GravisJPRN-UMIN000051155CB Japan Co.,Ltd.2,000
已完成
2 期
Phase II Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years With Alternating Bortezomib/dexamethasone (Bd) With Lenalidomide/dexamethasone (Ld).Multiple MyelomaJPRN-UMIN000013773Clinical Hematlogy Study Group of National Hospital Organization (CHSGONHO)35